Adenocarcinoma of Biliary Tract: Clinical Trials

2 trials for Adenocarcinoma of Biliary Tract, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 active not recruiting, 1 recruiting. 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 31Active not recruiting 1

Follow Adenocarcinoma of Biliary Tract: new trials by email Literature Review of Adenocarcinoma of Biliary Tract trials Research Report on Adenocarcinoma of Biliary Tract

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma (POELH-III)
Registration of all findings during preoperative Endoscopic Ultrasound - Hilar Cholangiocarcinoma, Intrahepatic Cholangiocarcinoma (Icc)
RecruitingErasmus Medical Center2502026-02-052026-09-10
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Atezolizumab, Bevacizumab - Colon Adenocarcinoma, Rectal Adenocarcinoma
Phase 3Active not recruitingGeorgetown University112023-03-292026-10-06

Narrower conditions

Biliary Tract Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Cirrhosis, Familial, with Pulmonary Hypertension (1)  ·  Colonic Neoplasms (1)  ·  Common Bile Duct Neoplasms (1)  ·  Klatskin Tumor (1)  ·  Rectal Neoplasms (1)

Broader conditions

Adenocarcinoma (2)  ·  Carcinoma (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms by Site (2)  ·  Neoplasms, Glandular and Epithelial (2)  ·  Bile Duct Diseases (1)  ·  Bile Duct Neoplasms (1)  ·  Biliary Tract Diseases (1)  ·  Colonic Diseases (1)  ·  Colorectal Neoplasms (1)  ·  Common Bile Duct Diseases (1)  ·  Gastrointestinal Diseases (1)

Interventions

Bevacizumab (1)  ·  atezolizumab (1)

Sponsors

Erasmus Medical Center (1)  ·  Georgetown University (1)

Countries

Netherlands (1)  ·  United States (1)

Top investigators

John L. Marshall, MD (1)